Advanced Enzyme Tech Share Price | Advanced Enzyme Tech Stock Screener
ADVENZYMES
Biotechnology
Share Price NSE
₹317.60
▲
4.15 (1.32%)
Share Price BSE
₹318.25
▲
4.65 (1.48%)
As of July 3, 2026, the Advanced Enzyme Tech share price (NSE: ADVENZYMES) is ₹317.60 on NSE and ₹318.25 on BSE, up 1.32% from the previous close, with shares trading between ₹314.00 and ₹327.95, and a 52-week range of ₹255.30–₹392.10.
Analyse ADVENZYMES share price history and track historical price performance.
Use the Advanced Enzyme Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Advanced Enzyme Tech Market Cap
₹3,439.91 Cr.
ADVENZYMES P/E Ratio (TTM)
20.82
Advanced Enzyme Tech P/B Ratio
2.21
EPS (TTM)
₹15.08
Dividend Yield
0.42%
Debt to Equity
0.03
ADVENZYMES 52 Week High
₹392.10
Advanced Enzyme Tech 52 Week Low
₹255.30
Operating Margin
31.00%
Profit Margin
21.33%
ADVENZYMES Revenue (TTM)
₹211.00
EBITDA
₹71.00
Net Income
₹45.00
Total Assets
₹1,839.00
Total Equity
₹1,632.00
Advanced Enzyme Tech Share Price Chart
Screen Advanced Enzyme Tech share price with an interactive chart. Analyse ADVENZYMES price trends and volatility across different timeframes.
Advanced Enzyme Tech Company Profile - Fundamental Screener
Screen Advanced Enzyme Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ADVENZYMES shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE837H01020
Advanced Enzyme Tech Balance Sheet Screener
Screen ADVENZYMES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,839 | 1,621 | 1,536 | 1,422 | 1,268 | 1,153 | 979 | 811 | 732 | 589 |
| Current Assets | 1,044 | 880 | 810 | 722 | 604 | 516 | 376 | 282 | 211 | 138 |
| Fixed Assets | 374 | 679 | 650 | 649 | 619 | 601 | 563 | 496 | 491 | 421 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 49 | 56 | 58 | 60 | 67 | 54 | 52 | 41 | 51 | 42 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,632 | 1,469 | 1,371 | 1,284 | 1,140 | 1,031 | 867 | 705 | 582 | 485 |
| Share Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves & Surplus | 1,610 | 1,399 | 1,302 | 1,213 | 1,066 | 948 | 817 | 657 | 537 | 442 |
Advanced Enzyme Tech Income Statement Screener - Profit & Revenue Analysis
Screen Advanced Enzyme Tech income statement and profit fundamentals.
Analyze ADVENZYMES quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Advanced Enzyme Tech share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 176 | 195 | 195 | 192 | 167 | 162 | 156 | 177 | 150 | 154 | 164 | 175 | 135 | 123 |
| Expenses | 140 | 122 | 130 | 125 | 123 | 118 | 103 | 104 | 114 | 99 | 103 | 107 | 107 | 91 | 90 |
| EBITDA | 71 | 54 | 65 | 70 | 69 | 50 | 58 | 52 | 63 | 51 | 51 | 57 | 68 | 44 | 33 |
| Operating Profit % | 31.00% | 27.00% | 30.00% | 33.00% | 29.00% | 26.00% | 33.00% | 29.00% | 33.00% | 29.00% | 30.00% | 33.00% | 33.00% | 31.00% | 26.00% |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 60 | 44 | 55 | 60 | 58 | 40 | 49 | 42 | 53 | 42 | 41 | 48 | 59 | 34 | 24 |
| Tax | 15 | 17 | 15 | 15 | 15 | 10 | 14 | 9 | 14 | 10 | 12 | 13 | 16 | 9 | 6 |
| Net Profit | 45 | 27 | 40 | 45 | 43 | 30 | 35 | 33 | 39 | 32 | 29 | 35 | 43 | 25 | 18 |
| EPS | 3.84 | 2.37 | 3.57 | 3.87 | 3.80 | 2.53 | 3.05 | 2.94 | 3.36 | 2.87 | 2.58 | 3.08 | 3.74 | 2.19 | 1.60 |
Advanced Enzyme Tech Cash Flow Screener - Liquidity Fundamentals
Screen ADVENZYMES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 143 | 141 | 140 | 122 | 163 | 141 | 129 | 116 | 107 | 93 |
| Investing Activities | -90 | -65 | -286 | 2 | -27 | -43 | -124 | -60 | -60 | -10 |
| Financing Activities | -73 | -59 | -26 | -49 | -26 | -39 | -43 | -2 | -65 | -63 |
| Net Cash Flow | -20 | 17 | -171 | 75 | 109 | 60 | -38 | 54 | -18 | 21 |
Advanced Enzyme Tech Shareholding Pattern Screener
See Advanced Enzyme Tech shareholding pattern with promoter, FII, and DII holdings.
Check Advanced Enzyme Tech promoter holding and ownership changes for ADVENZYMES on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.26% | 43.08% | 43.08% | 43.07% | 43.04% | 43.49% | 43.02% | 42.95% |
| FII Holding | 25.49% | 11.90% | 23.46% | 25.41% | 25.86% | 23.01% | 12.03% | 12.63% |
| DII Holding | 5.41% | 8.19% | 8.45% | 6.41% | 5.51% | 7.56% | 8.08% | 8.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.57% | 16.68% | 16.92% | 16.95% | 17.44% | 15.43% | 16.42% | 16.04% |
| Other Holding | 8.26% | 20.16% | 8.10% | 8.15% | 8.15% | 10.51% | 20.45% | 20.36% |
| Shareholder Count | 66,193 | 65,322 | 67,589 | 69,637 | 68,051 | 68,640 | 65,222 | 66,758 |
Advanced Enzyme Tech Share Dividend Screener - Share Yield Analysis
Check Advanced Enzyme Tech dividend history with payout and yield data.
View Advanced Enzyme Tech dividend details including ex-dates and amounts for ADVENZYMES stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.20 | 2.04% |
| 2024-March | ₹5.10 | 1.83% |
| 2023-March | ₹1.00 | 0.29% |
| 2022-March | ₹1.00 | 0.42% |
| 2021-March | ₹0.90 | 0.32% |
| 2020-March | ₹0.60 | 0.17% |
| 2019-March | ₹0.60 | 0.42% |
| 2018-March | ₹0.50 | 0.27% |
| 2017-March | ₹0.40 | 0.19% |
Advanced Enzyme Tech Stock Index Membership
See which indices include Advanced Enzyme Tech stock.
Check ADVENZYMES index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Advanced Enzyme Tech Market Events Screener - Corporate Actions
Get Advanced Enzyme Tech corporate actions including splits, bonuses, and buybacks.
Check Advanced Enzyme Tech stock events that may affect ADVENZYMES share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-09 | 2026-05-09 | Quarterly Result Announcement | NA | 2.67% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 9.05% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.24% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | 9.08% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | 17.48% |
| 2025-07-23 | 2025-07-23 | Dividend | ₹ 1.20 /share | 14.47% |
| 2025-05-16 | 2025-05-17 | Dividend | ₹ 4.00 /share | -2.19% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 3.73% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 0.59% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 8.58% |
| 2024-07-25 | 2024-07-25 | Annual General Meeting | NA | -0.83% |
| 2024-07-18 | 2024-07-18 | Dividend | ₹ 1.10 /share | -4.39% |
| 2024-05-17 | 2024-05-18 | Dividend | ₹ 4.00 /share | -5.22% |
| 2023-08-04 | 2023-08-05 | Dividend | ₹ 1.00 /share | 18.08% |
| 2023-05-19 | 2023-05-20 | Dividend | ₹ 4.00 /share | -4.88% |
Advanced Enzyme Tech Competitors Screener - Peer Comparison
Screen ADVENZYMES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 43,394 | 73.74 | 2,124 | 10.05% | 583 | 51.74 |
| Advanced Enzyme Tech | 3,440 | 20.82 | 746 | 11.31% | 176 | 27.89 |
| CCME Global | 565 | -781.25 | 4 | % | 0 | 66.64 |
| Vivo Bio Tech | 53 | -30.53 | 53 | 3.55% | 4 | 43.51 |
| Shree Ganesh Bio-Tech | 23 | 58.00 | 5 | -79.63% | 0 | 44.72 |
| Genomic Valley Biotech | 9 | 317.60 | 0 | -66.25% | 0 | 59.94 |
Advanced Enzyme Tech Company Announcements - News Screener
Screen ADVENZYMES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-30 | Closure of Trading Window | - |
| 2026-06-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-11 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-06-06 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-05-20 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Cancellation of Dividend | - |
| 2026-05-09 | Corporate Action-Board approves Dividend | - |
| 2026-05-09 | Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31 2026 | - |
| 2026-05-09 | Board Meeting Outcome for Outcome Of Board Meeting Held On May 09 2026 | - |
| 2026-05-06 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-02 | Board Meeting Intimation for Q4 Of FY 2026 | - |